切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2019, Vol. 13 ›› Issue (06) : 455 -458. doi: 10.3877/cma.j.issn.1674-0793.2019.06.008

所属专题: 文献

论著

原发性肝细胞癌肝移植预后相关因素的单中心研究
龚雪屹1, 朱晓峰2,(), 胡泽民3, 汪谦4   
  1. 1. 510080 广州,中山大学附属第一医院博士后流动站;528403 中山市人民医院普外一科
    2. 510080 广州,中山大学附属第一医院器官移植科
    3. 528403 中山市人民医院普外一科
    4. 510080 广州,中山大学附属第一医院胆胰外科
  • 收稿日期:2018-12-16 出版日期:2019-12-01
  • 通信作者: 朱晓峰
  • 基金资助:
    广东省医学科学基金项目(2015B1092)

Single center study on the related factors of prognosis of liver transplantation in hepatocellular carcinomapatients

Xueyi Gong1, Xiaofeng Zhu2,(), Zemin Hu3, Qian Wang4   

  1. 1. Postdoctoral Programme, the First Affiliated Hospital of Sun Yat-senUniversity, Guangzhou 510080, China;The First Department of General Surgery, Zhongshan City People’s Hospital, Zhongshan 528403, China
    2. OrganTransplantation Department, the First Affiliated Hospital of Sun Yat-senUniversity, Guangzhou 510080, China
    3. The First Department of General Surgery, Zhongshan City People’s Hospital, Zhongshan 528403, China
    4. Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-senUniversity, Guangzhou 510080, China
  • Received:2018-12-16 Published:2019-12-01
  • Corresponding author: Xiaofeng Zhu
  • About author:
    Corresponding author: Zhu Xiaofeng, Email:
引用本文:

龚雪屹, 朱晓峰, 胡泽民, 汪谦. 原发性肝细胞癌肝移植预后相关因素的单中心研究[J/OL]. 中华普通外科学文献(电子版), 2019, 13(06): 455-458.

Xueyi Gong, Xiaofeng Zhu, Zemin Hu, Qian Wang. Single center study on the related factors of prognosis of liver transplantation in hepatocellular carcinomapatients[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2019, 13(06): 455-458.

目的

了解原发性肝细胞癌(PHC)患者肝移植术后的临床病理因素和生存情况,分析影响其预后的危险因素。

方法

回顾性分析2015年1月至2016年12月中山市人民医院29例PHC肝移植患者临床资料,统计患者病理特征、围手术期效果和临床结局。对随访资料采用寿命表及Kaplan-Meier方法绘制生存曲线进行生存分析,筛选差异变量纳入Cox回归模型分析,研究影响PHC肝移植患者预后相关因素。

结果

29例PHC患者中采取经典原位肝移植25例,背驮肝移植4例。中位随访时间为23个月,失访3例,7例死于复发,生存时间为676.5(26~1 188)d,生存率为73.1%(19/26)。Cox回归分析结果显示,病理分级(P=0.018,95%CI:1.758~361.593)及淋巴结转移(P=0.003,95%CI:0.019~0.438)是影响26例患者预后生存的危险因素,病理分级每升高1级,其预后风险降低0.092倍,淋巴结转移患者预后风险升高25.216倍。

结论

肿瘤病理分级、淋巴结转移是影响PHC肝移植预后的重要因素。判断PHC肝移植预后,需要考虑患者淋巴结转移情况以及术后病理生理改变。

Objective

To investigate the clinicopathological factors and survival of patients with primary hepatocellular carcinoma (PHC) with liver transplantation, and to analyze the risk factors affecting their prognosis.

Methods

From January 2015 to December 2016, the clinical data of twenty-nine patients with liver transplantation for PHC in Zhongshan Peoples Hospital were retrospectively analyzed. Pathological features, clinical outcomes and perioperative effects were analyzed. Life table and Kaplan-Meier method were used for survival analysis of follow-up data, and differential variables were included in Cox regression model analysis to study the related factors affecting the prognosis of liver transplantation patients.

Results

Twenty-five cases received classical orthotopic liver transplantation and four cases received piggyback liver transplantation. The median follow-up time was 23 months, three cases were lost and seven cases died of recurrence. The survival time was 676.5 (26-1 188) days and the survival rate was 73.1% (19/26). Cox regression analysis showed that pathological stage (P=0.018, 95%CI: 1.758-361.593) and lymph node metastasis (P=0.003, 95%CI: 0.019-0.438) were risk factors for prognosis and survival. The prognostic risk of patients with lymph node metastasis increased by 25.216 times, and decreased by 0.092 times for each grade of pathological stage.

Conclusions

Tumor pathological staging and lymph node metastasis are important factors affecting the prognosis of liver transplantation for PHC. To judge the prognosis of liver transplantation for PHC, lymph node metastasis and pathophysiological changes should be considered.

图1 26例原发性肝细胞癌患者生存曲线
表1 影响26例原发性肝细胞癌患者生存的二分类变量单因素分析
表2 26例患者预后生存危险因素的Cox回归分析
[1]
Venook AP, Papandreou C, Furuse J, et al. The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective[J]. Oncologist, 2010,15 (Suppl 4): 5-13.
[2]
Mazzaferro V, Bhoori S, Sposito C, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience[J]. Liver Transpl, 2011, 17 (Suppl 2): S44-S57.
[3]
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-E386.
[4]
焦作义, 俞泽元. 原发性肝癌外科治疗进展[J/CD]. 中华肝脏外科手术学电子杂志, 2016, 5(5): 281-284.
[5]
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2): 74-108.
[6]
Pang TC, Lam VW. Surgical management of hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(2): 245-252.
[7]
Ramesh H. Resection for hepatocellular carcinoma[J]. J Clin Exp Hepatol, 2014, 4(Suppl 3): S90-S96.
[8]
Strassburg CP. HCC-associated liver transplantation-Where are the limits and what are the new regulations?[J]. Visc Med, 2016, 32(4): 263-271.
[9]
Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2012, 379(9822): 1245-1255.
[10]
Mazzaferro V, Chun YS, Poon RT, et al. Liver transplantation for hepatocellular carcinoma[J]. Ann Surg Oncol, 2008, 15(4): 1001-1007.
[11]
解恩博, 轩凤慧, 孙晓东, 等. 肝移植术后早期并发症的危险因素分析[J]. 临床肝胆病杂志, 2018, 34(6): 1282-1288.
[12]
唐腾骞, 卢倩, 刘祥德, 等. 肝移植术后肝癌复发转移患者的治疗及其预后分析[J]. 中华消化外科杂志, 2012, 11(6): 538-540.
[13]
杨滔, 周宁新, 史宪杰, 等. 影响原发性肝癌肝移植治疗的预后因素分析[J]. 消化外科, 2005, 4(5): 311-315.
[14]
吕波, 张宇, 廖志学, 等. 肝癌肝移植术后肝癌复发转移的特点及危险因素[J]. 四川医学, 2010, 31(5): 603-605.
[15]
陈冠中, 张彤, 孟炜, 等. 肝癌肝移植生存情况及预后影响因素分析(附109例报告) [J]. 器官移植, 2010, 1(5): 287-290.
[16]
吕少诚, 潘冰, 李立新, 等. 不同肝癌肝移植标准受者预后分析[J/CD]. 中华移植杂志(电子版), 2015, 13(3): 206-209.
[1] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[2] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[3] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[4] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[5] 林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[6] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[7] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[8] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[9] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[10] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[11] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[12] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[13] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[14] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要